All Industries

Top Therapeutics Companies

765 Therapeutics companies, sorted by total funding raised.

Gracell BioAcquired

Clinical-stage biopharmaceutical company developing innovative CAR-T cell therapies for cancer an...

11–50Biotech, Therapeutics
Private EquityTotal funding$150.0MAug 2023
Big Health

Digital therapeutics company providing clinically proven cognitive behavioral therapy programs fo...

San Francisco, United States51–200Digital Health, Therapeutics
Extension RoundTotal funding$149.7MFeb 2026
Shape Therapeutics

A development stage biotechnology company based in Seattle WA and San Diego CA that is establishi...

Seattle, United States51–200Artificial Intelligence, Biotech
Series BTotal funding$147.5M
BreezeBio

Nanoparticles for genetic medicine delivery

Brisbane, Australia51–200Biotech, Therapeutics
Series BTotal funding$142.5MFeb 2026
ArdelyxIPO

Focused on the discovery and development of novel therapeutics acting exclusively in the gastroin...

Fremont, United States201–500Biotech, Healthcare
Private EquityTotal funding$140.0MJul 2016
Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals develops novel chemical entities for psychiatric disease, using medicin...

New York, United States11–50Healthcare, Mental Health
Series ATotal funding$140.0MMar 2026
Congruence Therapeutics

Congruence Therapeutics discovers small-molecule correctors and allosteric modulators that restor...

Montreal, Canada11–50Biotech, Drug Discovery
Series BTotal funding$137.0MMar 2026
SalioGen Therapeutics
Biotech, Genomics
Series BTotal funding$135.0MJan 2022
Allay Therapeutics

Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pa...

San Jose, United States11–50Biotech, Healthcare
Series DTotal funding$133.5MJun 2025
SurrozenIPO

Surrozen is a clinical-stage biotech developing Wnt pathway-based regenerative medicines, with a ...

South San Francisco, United States11–50Biotech, Healthcare
Series CTotal funding$133.0MJun 2020
Pretzel Therapeutics

Develops therapeutics that restore mitochondrial function for rare and common diseases using geno...

Waltham, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$131.8MAug 2024
CHARM Therapeutics

AI-driven biotech developing next-generation menin inhibitors and small-molecule therapeutics for...

London, United Kingdom11–50Life Sciences, Biotech
Series BTotal funding$130.0MSep 2025
EdiGene

Biotech company developing genome editing technologies for drug discovery and therapeutics.

Beijing, ChinaBiotech, Therapeutics
Series BTotal funding$129.0MApr 2021
Monte Rosa TherapeuticsIPO

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing molecular glue degra...

Boston, United States51–200Biotech, Drug Discovery
Series CTotal funding$127.5MMar 2021
AXONIS THERAPEUTICS, INC.

Axonis Therapeutics is a Boston biotechnology company developing oral KCC2-targeting medicines fo...

Boston, United States11–50Biotech, Neurotechnology
Series ATotal funding$127.5MOct 2024
Nkarta TherapeuticsIPO

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural ...

South San Francisco, United States51–200Biotech, Oncology
Series BTotal funding$126.8MSep 2019
Gate Bioscience

Biotechnology company developing oral small-molecule ‘molecular gates’ to eliminate disease-causi...

California, United States11–50Biotech, Drug Discovery
Series BTotal funding$125.0MNov 2025
OnCusp Therapeutics

Clinical-stage biopharma developing targeted oncology therapeutics and ADCs to advance treatments...

Princeton, United States11–50Biotech, Healthcare
Series ATotal funding$125.0MJan 2024
Epic Bio

Epic Bio (now Epicrispr Biotechnologies) develops epigenetic gene therapies using ultracompact CR...

South San Francisco, United States11–50Biotech, Therapeutics
Series BTotal funding$123.0MMar 2025
MetacrineIPO

Metacrine is a biotech company developing innovative therapeutics for liver, gastrointestinal, an...

San Diego, United States11–50Biotech, Therapeutics
Series CTotal funding$123.0MJun 2018
Pegbio (派格生物)

Biotech company researching and developing innovative therapies for chronic disease

Hangzhou, ChinaBiotech, Healthcare
Venture RoundTotal funding$122.0MDec 2020
Ouro Medicines

Biotechnology company dedicated to developing immune reset therapeutics for people living with ch...

USA, United States11–50Biotech, Drug Discovery
Series ATotal funding$120.0MJan 2025
Shinobi Therapeutics

Shinobi Therapeutics engineers immune-evasive iPSC-derived cell therapies for cancer and autoimmu...

San Diego, United States11–50Biotech, Therapeutics
Extension RoundTotal funding$119.0MAug 2024
Dyno

AI and biotech pioneer building capsid technology that enables gene therapy developers to target ...

Watertown, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$118.0MMay 2021
AbCellera BiologicsIPO

Biopharmaceutical company developing antibody-based therapeutics for biopharma partners.

Vancouver, Canada501–1000Biotech, Healthcare
Series BTotal funding$115.8MMay 2020